<DOC>
	<DOC>NCT00018148</DOC>
	<brief_summary>Treatment of smokers with a tricyclic antidepressant, nortriptyline, can reduce tobacco withdrawal symptoms and increases long term cessation rates when combined with transdermal nicotine and a behavioral cessation programs. The study is a placebo-controlled, randomized, parallel group trial in which smokers aged 18-70 will be subject to the combination of oral and patch treatments.</brief_summary>
	<brief_title>Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Nortriptyline</mesh_term>
	<criteria>Aged 1870, smoking &gt; 10 cigarettes per day, no current major depression, no concurrent psychiatric medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>smoking cessation</keyword>
</DOC>